Market Overview:
The Global Cromoglicate Acid API Market is expected to grow at a CAGR of XX% and is projected to reach USD XX million by 2030. The market growth is attributed to the increasing demand for cromoglicate acid API in the pharmaceutical industry, research organizations, and others. However, the high cost of cromoglicate acid API may restrain the market growth during the forecast period. Based on type, the global cromoglicate acid API market has been segmented into abrove purity 98% and purity 99%. The purity 99% segment is expected to grow at a higher CAGR during the forecast period owing to its increased demand in various applications. Based on application, the global cromoglicate acid API market has been divided into pharmaceutical industry, research organization, and others. The pharmaceutical industry segment dominates this market due to rising prevalence of respiratory diseases across different geographies. Region-wise, North America dominates this market followed by Europe due to early adoption of novel technologies in these regions coupled with presence of key players operating in these regions.
Product Definition:
Cromoglicate acid is an API used in the treatment of asthma and other respiratory conditions. It helps to prevent the release of histamines, which can cause inflammation and constriction of the airways. This makes cromoglicate acid an important tool for managing respiratory conditions.
Abrove Purity 98%:
Cromoglicate acid is a preferred solvent for the production of pharmaceutical drugs. It is also used as an intermediate in the manufacturing of specialty chemicals and agrochemicals. Abrove purity 98% has been developed to serve as a suitable alternative to conventional solvents such as chloroform and dichloromethane in chemical processing applications.
Purity 99%:
Cromoglicate acid is a by-product obtained during the manufacturing process of sodium cromoglycate. It is an odorless, colorless liquid that has a saline taste. Cromoglicate acid can be derived from both natural and synthetic sources. The majority of the commercially available products are manufactured using chemical synthesis or fermentation processes with some minor production based on biological methods.
Application Insights:
The pharmaceutical industry accounted for the largest share of over 30% in 2017. The product is used as a raw material for the manufacturing of various drugs, such as paracetamol, aspirin, and others. The demand from this sector is expected to remain strong over the forecast period owing to extensive usage in drug formulations that are available OTC without a prescription.
In addition to being an essential chemical used in several formulations across various industries including healthcare and cosmetics; it also finds applications as an additive/enhancer for plant growth regulators (herbicides), surfactants (detergents), emulsifiers (paints & coatings) and dispersants among others.
Regional Analysis:
North America accounted for the largest share of over 35% in 2017. The U.S., in particular, is one of the major consumers owing to high R&D investments and a strong pharmaceutical industry. Moreover, increasing demand for generic drugs due to patent expirations and regulatory reforms will drive the regional market over the forecast period.
Asia Pacific is expected to be one of the fastest-growing regions during the forecast period owing to growing product demand from emerging countries such as China and India that are adopting advanced technologies at a faster pace than other developing nations across this region.
Growth Factors:
- Increasing prevalence of respiratory diseases: The global prevalence of respiratory diseases is increasing due to the changing lifestyle and environmental factors. This is expected to drive the demand for Cromoglicate Acid API in the coming years.
- Growing awareness about asthma and its treatment: There is a growing awareness among people about asthma and its treatment options. This is likely to boost the demand for Cromoglicate Acid API in the near future.
- Rising number of product approvals: The number of product approvals for Cromoglicate Acid API is rising, owing to its therapeutic benefits over other drugs used for treating respiratory diseases such as asthma, COPD, and bronchitis. This will propel market growth in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Cromoglicate Acid API Market Research Report
By Type
Abrove Purity 98%, Purity 99%
By Application
Pharmaceutical Industry, Research Organization, Others
By Companies
Cambrex, LGM Pharma, JSN Chemicals, DEAFARMA, P&R SpA, SIMS Srl, Sanofi Active Ingredient Solutions, Fermion Oy, Egis Pharmaceuticals PLC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
211
Number of Tables & Figures
148
Customization Available
Yes, the report can be customized as per your need.
Global Cromoglicate Acid API Market Report Segments:
The global Cromoglicate Acid API market is segmented on the basis of:
Types
Abrove Purity 98%, Purity 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Industry, Research Organization, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cambrex
- LGM Pharma
- JSN Chemicals
- DEAFARMA
- P&R SpA
- SIMS Srl
- Sanofi Active Ingredient Solutions
- Fermion Oy
- Egis Pharmaceuticals PLC
Highlights of The Cromoglicate Acid API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Abrove Purity 98%
- Purity 99%
- By Application:
- Pharmaceutical Industry
- Research Organization
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cromoglicate Acid API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cromoglicate Acid API is a synthetic acid used in the production of pharmaceuticals and other chemicals.
Some of the major companies in the cromoglicate acid api market are Cambrex, LGM Pharma, JSN Chemicals, DEAFARMA, P&R SpA, SIMS Srl, Sanofi Active Ingredient Solutions, Fermion Oy, Egis Pharmaceuticals PLC.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cromoglicate Acid API Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cromoglicate Acid API Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cromoglicate Acid API Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cromoglicate Acid API Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cromoglicate Acid API Market Size & Forecast, 2020-2028
4.5.1 Cromoglicate Acid API Market Size and Y-o-Y Growth
4.5.2 Cromoglicate Acid API Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Abrove Purity 98%
5.2.2 Purity 99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pharmaceutical Industry
6.2.2 Research Organization
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cromoglicate Acid API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cromoglicate Acid API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Abrove Purity 98%
9.6.2 Purity 99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pharmaceutical Industry
9.10.2 Research Organization
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Abrove Purity 98%
10.6.2 Purity 99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pharmaceutical Industry
10.10.2 Research Organization
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Abrove Purity 98%
11.6.2 Purity 99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pharmaceutical Industry
11.10.2 Research Organization
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Abrove Purity 98%
12.6.2 Purity 99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pharmaceutical Industry
12.10.2 Research Organization
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Abrove Purity 98%
13.6.2 Purity 99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pharmaceutical Industry
13.10.2 Research Organization
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cromoglicate Acid API Market: Competitive Dashboard
14.2 Global Cromoglicate Acid API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Cambrex
14.3.2 LGM Pharma
14.3.3 JSN Chemicals
14.3.4 DEAFARMA
14.3.5 P&R SpA
14.3.6 SIMS Srl
14.3.7 Sanofi Active Ingredient Solutions
14.3.8 Fermion Oy
14.3.9 Egis Pharmaceuticals PLC
